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Background. Hospitalization accounts for 70% of heart failure (HF) costs; readmission rates at 30 days are 24% and rise to 50% by
90 days. Agencies anticipate that telehomecare will provide the close monitoring necessary to prevent HF readmissions. Methods
and Results. Randomized controlled trial to compare a telehomecare intervention for patients 55 and older following hospital
discharge for HF to usual skilled home care. Primary endpoints were 30- and 60-day all-cause and HF readmission, hospital days,
and time to readmission or death. Secondary outcomes were access to care, emergency department (ED) use, and satisfaction with
care. All-cause readmissions at 30 days (16% versus 19%) and over six months (46% versus 52%) were lower in the telehomecare
group but were not statistically significant. Access to care and satisfaction were significantly higher for the telehomecare patients,
including the number of in-person visits and days in home care. Conclusions. Patient acceptance of the technology and current
home care policies and processes of care were barriers to gaining clinical effectiveness and efficiency.
1. Introduction
Heart failure (HF) is the most common chronic illness in
home care, affecting almost six million Americans today. HF
costs $39.2 billion annually in the US [1], with hospitaliza-
tions accounting for 70% of HF costs [2]. Readmission rates
at 30 days are 24% nationwide [3] and rise to 50% by 90 days
[4–6], though half of these readmissions may be preventable
[6]. With a hospital fatality rate of 51% [1], and with each
hospitalization costing $7,174–$10,000 [7], it is imperative
to prevent or reduce readmissions.
Symptoms of heart failure exacerbation, such as weight
gain, edema, and increased dyspnea, frequently present 8 to
12 days before admission [8]. Using daily remote monitoring
these symptoms can be recognized and treated before read-
mission becomes necessary. Increasing incidence and preva-
lence of HF [9], “quicker and sicker” hospital discharges [10],
and the current nursing shortage [11] make it challenging
to efficiently provide the necessary close monitoring and
teaching that HF patients require.
Telehomecare is defined as a communication and clinical
information system that enables the interaction of voice,
video, and health-related data using ordinary telephone lines
from the patients’ homes in conjunction with home visits
[12]. The intent is for patients to use the equipment to self-
monitor, then actively partner in collaboration with health
care providers to manage symptoms. The evidence to date on
the cost and clinical effectiveness of telehomecare monitoring
is mixed and difficult to interpret as a body of evidence
[2, 8, 10, 13–25]. Most studies have small sample sizes and
lack standardization of the intervention making it difficult to
synthesize results.
All previous studies provided telehomecare in addition
to usual care, leading our team to question if using it as a
substitute for some routine home visits might increase its
efficiency. This study was the first attempt to test the effects of
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telehomecare when used in collaboration with the patient in
place of some in-person skilled nursing visits. Many authors
claim that telehomecare is capable of maintaining quality of
care while creating potential for cost savings [26] through
higher patient : nurse ratios [27, 28] and decreased travel
costs [29, 30]. Others say it may be possible to conduct
about 45% of home care visits through telehomecare, yield-
ing savings of up to $700 per patient [31, 32]. Based on
these estimates, 15–25 patients a day can access care via
video telehomecare technology versus, on average, a driving
visiting nurse can only see 5-6 patients per/day. Agencies that
utilize telehomecare actually increase their patient’s access
to care by performing standard in-home visits, remotely
monitoring, and allowing patients to transmit data as often
as they choose. The challenge lies in achieving the balance
between meeting patient care goals and efficiency.
The purpose of this study was to compare the effects
of a telehomecare intervention that substitutes for 45% of
in-person skilled nursing visits on time to readmission,
readmission rates, hospital days, emergency department use,
access to care, and satisfaction for older adults following
hospital discharge for HF to standard skilled home care
services.
2. Methods
2.1. Design. This study was a randomized, controlled clinical
trial conducted as a field study with 217 HF patients in
a not-for-profit home care agency in Philadelphia. The
intervention group (N = 101) received home care consisting
of a combination of in-person and telehomecare daily mon-
itoring and intermittent video visits. The type and number
of visits were guided by a standardized study protocol that
defined minimal expectations of at least four video visits
and daily use of the devices over the home care episode
and at least 5 in-person home visits for either group. The
goal was for the home care nurse to collaborate with the
patient to use the technology in place of 45% of the skilled
nursing in-person visits. The intervention occurred over an
episode of home care, from the initial start of care until
officially discharged from the home health agency. Outcomes
were assessed at 30, 60, 120, and 180 days. All of the
nurses involved in caring for both standard care/control and
intervention subjects were guided by the agency’s evidence-
based clinical pathway for HF management. Both groups
aimed to monitor and teach patients how to self monitor
and manage their needs following discharge from home care,
but the standard care nurses and patients (n = 116) did so
without the technology.
2.2. Sample. The sample was drawn from all patients 55
and older discharged from area hospitals within two weeks
of enrollment for HF as a primary or secondary diagnosis
and referred to home care with the study agency. Patients in
another HF clinical trial, on dialysis, on the heart transplant
list, with cancer as a primary diagnosis, or in disease
management were excluded. Eligible patients spoke English;
were mentally competent as determined by the Mini Cog test
[33, 34]; weighed less than 450 pounds (scale maximum);
had a land line telephone; were able to see, hear, place a cuff
on their arm, and stand on a scale to weigh themselves; and
were eligible for, referred to, and accepted home care services.
The protocol was approved by the university institutional
review board and written informed consent was obtained
before randomization.
Power calculations were based on home care agency
reported 60-day readmission rates of 37% at the time of study
planning. Unpublished pilot work and experience in other
studies indicated that the readmission rate may decrease to
19% using telehealth [35, 36]. Thus, if the readmission rate
in the telehomecare group is half that of the usual care, the
anticipated difference was 19% with alpha = 0.05 yielding
power of 0.80. This would require a sample size of 90 per
group (or 180 total subjects). To account for the anticipated
effect of a 20% attrition rate, we targeted 108 subjects per
group for a total of 216 subjects. The principle investigator
and research assistants remained blinded to study group. It
was not possible to blind the patients or the home care nurses
since they had to interact with the telehealth equipment.
Enrolled patients were randomized by the project manager
using an allocation spreadsheet prepared by the statistician
using a randomly permuted blocks algorithm to insure equal
distribution between the two groups. The sample was strat-
ified on length of time since HF diagnosis: less than two
months versus more than or equal two months based on
research that demonstrated significant differences in HF self-
care between patients diagnosed less than two months and
those diagnosed more than or equal two months [37]. En-
rollment began in March 2006 and ended in November 2009.
2.3. Procedures. Patients assigned to the telehomecare group
received telehealth equipment in their homes and nurses
followed the intervention group protocol described below.
The home care nurse manager and visiting nurse at the home
care agency were notified of patient group assignment; so the
nurse knew to expect the arrival of telehomecare equipment
and to follow the telehomecare protocol versus usual care.
Usual home care consists of at least five intermittent in-
person skilled visits by a registered nurse over a 60-day
episode to assess, teach, and case manage the patient’s care.
Two education sessions were held with all the agency
field nurses and their managers at the start of the study
with six refresher sessions conducted throughout the course
of the study in addition to personal sessions by the project
manager as needed. All agency nurses (N = 52) attended the
education sessions to learn about heart failure management,
how to apply the clinical pathway, install and operate the tele-
health equipment, teach patients how to use the equipment,
and details about the study protocol to guide substitution
of telehomecare visits for in-person visits. Randomization
of the nurses was not possible because they are assigned to
patients by geographic area and cover for each other on days
off and vacations. Logistically it would have impaired the
agency operations. Therefore, the patients were randomized
and the same nurses cared for patients in either group and
used the clinical pathway to guide the care whether the
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Table 1: Visit protocol for telehealth patients.
Week 1 2 in-home visits
Week 2 1 in-home; 1 video visit (nurses/patients collaborate on the plan of care)
Week 3 1 in-home; 1 video visit (nurses/patients collaborate on the plan of care)
Week 4 2 video visits
Week 5 2 video visits
Decision point
Week 6
1 video visit; Nurses determine if it is time to discharge the patient or whether the patient could benefit from
two more weeks of telehealth monitoring and teaching. If discharged, the nurse goes to the home (visit 5) to
make the discharge visit, completes the discharge OASIS, and packs the telehealth equipment for return.
If not discharged at week 6, the video nurse continues one video visit per week for weeks 7 and 8 and then
goes into the home for the final visit to either close the case or recertify.
patient was receiving telehealth monitoring or not. This was
instituted to ensure a consistent baseline of standard care;
so the telehealth technology and substituted visit pattern
become the only difference between the groups. The pathway
guided the schedule of assessments and teaching topics for
each week of the home care episode. Over the course of the
study 28 nurses among the 52 trained cared for study patients
as they were admitted in their geographic locations. None of
the nurses had prior experience with telehomecare.
Once the patient was randomized to group, the project
manager ordered the telehealth equipment based on patient
need. For example, if they had diabetes or chronic obstructive
pulmonary disease in addition to HF, they received a
glucometer and pulse oximeter, respectively. All patients
received a video phone, blood pressure cuff, and a weight
scale. The equipment was shipped to the patients’ home
within the first week of home care and installed either by the
patient and family or by the home care nurse on the first visit.
Installation success was tested remotely by the project man-
ager. The devices were wireless for easy placement through-
out the home and transmitted data via a hub automatically
every day that connected to the Internet via a telephone
line. Nurses taught the patients and their caregivers how to
operate the equipment and reviewed the study goals. Patients
were taught to use the devices daily by 11 am and a telehealth
nurse at the agency monitored the data daily for out of
range readings. The devices were supplied by Carematix, Inc.
Chicago, Illinois. According to protocol, the telehomecare
nurse was to make at least four video visits with the patient
in addition to their daily monitoring. Video visits were
considered important for teaching and to replace personal
contact as home visits were decreased. The home care nurses
conducted the in-person home visits and four telehomecare
nurses monitored the data and conducted the video visits.
The telehomecare nurses notified the home visiting nurses
and/or patient via phone or voicemail if readings were out
of normal range to obtain changes in the treatment plan or
confirm the accuracy of the transmission with another read-
ing (i.e., blood pressure) or assessment of other symptoms
(shortness of breath). The telehomecare nurses and visiting
nurses collaborated on the plan of care and determined
when to notify a physician of symptoms or changes in the
measures. It was not feasible for the telehomecare nurses and
the home visiting nurses to be the same person because the
home care nurses did not travel back to the office which was
required to conduct the video visits. Once out in the field
visiting it would not be cost effective to have them drive in to
do a video visit. It would also have been difficult to schedule.
The project manager gave a suggested visit pattern to
each nurse to guide the substitution pattern (Table 1). A
rigorous process was followed to encourage that the visit
protocol was followed starting with education, six refresher
classes, monitoring by the project manager, and one-on-
one communication with the nurses. The visit protocol was
provided to every nurse caring for a telehealth patient in a
folder upon admission. The project manager monitored the
visit pattern and was in contact with the nurses throughout
the home health episode encouraging that the visit protocol
be followed. For the occasions when it was detected that the
visit pattern was not being followed, the project manager
contacted the nurse directly to discuss why and reviewed the
study protocol as well as notified the nurse’s manager. The
refresher inservices and the project manager’s individualized
coaching of field nurses were in addition to periodic contact
between the principal investigator and agency executive
administration in an attempt to obtain the support needed
for protocol adherence.
2.4. Data Collection and Outcome Measures. Consenting
patients were interviewed at baseline (enrollment day 0) in
person or by telephone by trained and blinded bachelor’s
nursing student research assistants and by telephone at 60,
120, and 180 days. Information about readmissions, ED
use, and length of stay was also collected from the hospital
administrative database and medical records departments.
2.4.1. Health Care Utilization. The effects of the telehome-
care intervention were measured on the primary outcome
health care resource utilization at 30 and 60 days which
included length of time to first rehospitalization or death,
numbers of all-cause and heart failure-related rehospitaliza-
tions, hospital days, and emergency department visits. The
health care utilization information was collected from the
home care agency records, the health system administrative
database, and patient interview. All readmissions occurring
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outside of the health system were confirmed through hospital
medical record departments. Data were collected on the date,
reason, location, length of stay, and cost of all readmissions.
2.4.2. Access to Care. Access to care was defined as the
amount of patient-provider contact via in-person home
visits and telehomecare visits. This was collected from the
home care agency records.
2.4.3. Patient Satisfaction. Satisfaction with home care was
measured by telephone survey upon discharge from home
care by the blinded research assistants. The survey was
designed specifically for home health care patients and was
tested in a sample of 696 patients from thirteen home health
agencies in Pennsylvania and Ohio. Construct validity was
obtained in a pilot test using home health nurses. The
reliability of the scale was 0.94. The tool measures aspects
of scheduling, nursing interventions and relationships, dis-
charge plans, and general measures of satisfaction [38]. It
did not specifically address telehealth but rather was an
assessment of satisfaction with home care services. Response
categories ranged from 1 to 5, with higher scores indicating
higher levels of satisfaction. The survey takes approximately
10 minutes to administer.
2.5. Data Analysis. All analyses were conducted using an
intent-to-treat approach, such that all randomized patients
are analyzed in the treatment groups to which they were
randomly assigned. Subjects having at least one follow-up
data point qualified for inclusion.
Descriptive statistics were used to characterize demo-
graphic and clinical characteristics, with means/standard
deviations representing continuous measures and frequen-
cies/percents representing categorical variables. Compar-
isons by intervention group were examined using chi-
square statistics and two-sample t-tests for categorical and
continuous variables, respectively. Covariates demonstrating
imbalance at the 0.10 level of significance were included in
subsequent multivariate modeling.
2.5.1. Time to Rehospitalization or Death. Time to first rehos-
pitalization or death was measured from the date of the
index hospitalization discharge to the date of first re-
hospitalization or death. Patients alive and remaining free
from hospitalization were censored at their last follow-up
interview date. A multivariate analysis of time to first re-
hospitalization or death was accomplished using Cox
proportional hazards regression modeling, with outcome
regressed on intervention group and adjusted for covari-
ates emerging significant on bivariate analysis [39]. Haz-
ard ratios are provided for intervention and covariates,
along with their 95% confidence intervals. The propor-
tional hazards assumption was examined and satisfied [40].
Kaplan Meier estimates were generated and used to visually
demonstrate time to first rehospitalization or death by
intervention group; the log-rank test was used for univariate
intervention group comparisons [41, 42].
2.5.2. Number of All-Cause and Heart Failure-Related Read-
missions, Hospital Days, and ED Visits. Poisson GEE [43]
models (log link) were used to model the total number of
rehospitalizations and hospital days through 180 days, with
an offset term of the natural logarithm of days included
to control for varying days at risk for rehospitalization
over the time period based on hospitalization or death. A
working exchangeable correlation matrix was used to model
repeated observations on the same person. To evaluate group
differences in outcome over time, and thus explore temporal
intervention effects, independent variables initially included
intervention group, time (30, 60, 120, 180 days), and a time-
by-group interaction term, as well as important covariates
emerging significant in preliminary analyses. Subsequent
models were based on main effects only (group, time, covari-
ates), given that changes over time by group were clinically
and statistically insignificant. Exponentiated parameter esti-
mates can be interpreted as rate ratios (RRs), estimating the
relative change in incidence rate associated with differences
in level for categorical predictors, or with a one unit change
in the independent variable for continuous variables.
2.5.3. Access to Care. Total number of home visits and length
of stay in home care were calculated from index home care
admission to discharge. Patients kept on service for another
episode of home care were counted as recertified and their
visits and days were included in the total visit count and
length of stay. Patients that accepted versus refused the
telehealth equipment were compared on severity of illness;
time with HF; number of medications, previous hospitaliza-
tions in six months, and comorbid conditions; and socio-
demographics (race, gender, income). The number of video
visits conducted was summarized and the percent of tele-
health use was calculated as the number of days the patient
used the equipment divided by the number of days the
equipment was in the home ×100. Chi square or t-tests were
used to compare the groups on characteristics of those who
refused versus accepted telehealth. The independent sample
Mann Whitney U-test was used to compare the number of
home visits, mean number of visits over the study period,
and the length of stay in home care. The two-sided Fishers
Exact test was used to assess the association between group
and recertification.
2.5.4. Patient Satisfaction. Descriptive statistics and chi
square were used to compare satisfaction scores between the
usual care group and the telehomecare group.
3. Results
Figure 1 shows the consort diagram where 1,119 patients
were screened, 644 were found ineligible (58%), and 257
refused to participate (23%). The most frequent reasons for
ineligibility were no referral to home care (18%), unable
to reach for enrollment prior to two weeks after discharge
(16%), cognitive impairment (11%), or unable to hear well
enough on the phone (6%). Two hundred and eighteen
patients were enrolled in the study and randomly assigned
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Flow of study participants
1119 patients assessed for eligibility
901 excluded
644 did not meet inclusion criteria
257 refused to participate
116 included in primary analysis 101 included in primary analysis
116 randomized to receive control
92 continued control as randomized
6 died
18 withdrew from study
218 randomized
102 Randomized to receive intervention
65 continued intervention as randomized
6 died
31 withdrew from study
1 found ineligible heart transplant
Figure 1: Consort diagram.
by the project manager. The stratification based on length
of time in months with heart failure was successful with the
control group mean at 61.4 months, SD = 71.6 and tele-
homecare patients at 60.1 months, SD = 67.6, P = 0.81. One
patient randomized to the telehomecare group was removed
before analysis because he/she was found to be ineligible (on
the heart transplant list and transplanted), making the final
sample 217, usual care 116, and telehomecare 101.
Of the 101 patients enrolled in the telehomecare group,
36 (36%) did not receive any dose of telehomecare but were
still included in the intent to treat analysis. Of these, 24
refused the equipment upon arrival, eight were discharged
from home care before delivery, three changed their minds
about being in a study, and one died before delivery. Reasons
for non acceptance of the equipment included patients being
“too sick to bother”, or some expressed concern over nurses
altering their phone systems to connect the equipment, and
two refused because the nurses discouraged them from par-
ticipating since the nurse had to set up the equipment.
Younger patients were significantly more likely to accept the
technology than older patients (mean age 69, SD 10.6 versus
74.5, SD 8.5, P 0.015).
Withdrawals (N = 31) in the telehomecare group
include the 24 who refused the equipment upon arrival and
seven who withdrew later (31%) compared to 18 (16%)
withdrawals in the control group. Only one patient was
lost to follow-up in the telehomecare group because he/she
was discharged early from home care, while in the control
group 15 patients (13%) were unable to be reached after
enrollment. All subjects were followed for six months. Five
patients died in the control group (4.3%) and four in the
telehomecare group (3.9%), (P = 0.822). Although patients
withdrew or were lost to follow-up for phone interviews,
data on the primary health care utilization outcomes were
available for all study subjects from agency databases; so
missing data are not an issue for the primary outcomes.
3.1. Sociodemographic and Clinical Comparisons. Table 2
shows the socio-demographic and clinical characteristics of
all enrolled patients at baseline. Telehomecare patients were
taking significantly more medications, mean 11.3, SD 4.6,
compared to mean of 10.0, SD 3.4 for control patients, P =
0.020. Telehomecare patients were younger, mean age 71.3
(SD = 10.2) versus 73.5 (SD = 9.6) for control patients,
P = 0.092. All analyses were adjusted for these differences.
Overall, study patients had high-risk characteristics such
as 69% rated their health as fair or poor, 32% had less than
a high school education, 65% were African American, 39%
had an annual income < $20,000/year, 69% were hospitalized
at least twice in the 12 months prior to enrollment, and 34%
lived alone and had an average of 6.4 comorbid conditions.
3.2. Time to First Readmission or Death. In Figure 2 the
Kaplan-Meier Survival Curve and log rank test shows that
there is no significant difference in time to readmission or
death between intervention and control group (log-rank
P = 0.585). A Cox proportional hazards model was used to
compare intervention and control group for the time to first
readmission adjusting for age and number of medications.
Table 3 shows that there is no significant difference between
the two groups (P value = 0.319).
3.3. Number of All-Cause and Heart Failure-Related Readmis-
sions. By 30 days, 19% of control group patients and 16% of
telehomecare patients had at least one all cause readmission;
however this 3% difference was not statistically significant
(P = 0.546). By six months 52% (n = 60) versus 46% (n =
46) of control versus intervention patients were readmitted
at least once (Table 4). The difference in overall percent of
patients experiencing readmissions over six months is 6%
and remained statistically insignificant, with P = 0.363, but
clinically relevant with telehomecare patients having fewer
readmissions.
Similarly, there were no significant differences in the
number of heart failure-related readmissions (Table 4). For
example, by 30 days 9% of usual care patients were read-
mitted for heart failure and 8% of telehomecare patients.
Overall, including 0–30 days, 31–60 days, 61–120 days, and
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Table 2: Sociodemographic and baseline clinical characteristics of ITT subjects by treatment group.
Variable
Telemed (N = 101) Control (N = 116) P-value1
n % n %
Gender
Male 36 35.6 39 33.6 0.755
Female 65 64.4 77 66.4
Ethnic Group
Hispanic or Latino 0 0 2 1.7 0.185
Not Hispanic or Latino 101 100 114 98.3
Race
white 33 32.7 39 33.6
0.727
black or AA 66 65.3 75 64.7
Asian 0 0 1 0.9
Native Hawaiian or other pac. islander 0 0 0 0
Am. Indian/Alaska native 1 1 1 0.9
no response 1 1 0 0
Marital Status
Married 28 27.7 28 24.3
0.315
Widowed 35 34.7 51 44.3
Separated 7 6.9 3 2.6
Divorced 17 16.8 14 12.2
Single 14 13.9 19 16.5
Education
Grades 1–4 1 1 0 0
0.770
Grades 5–8 9 8.9 11 9.6
High school incomplete 21 20.8 27 23.5
High school complete 49 48.5 43 37.4
Post HS/Bus or trde school 3 3 4 3.5
1–3 years college 8 7.9 15 13
College completed 5 5 7 6.1
Post graduate college 4 4 7 6.1
No response 1 1 1 0.9
Work history
Full-time 0 0 0 0
0.282
Part-time 3 3 1 0.9
Retired, not working 68 69.3 72 62.6
Retired, BUT working 5 5 4 3.5
Retired on disability 20 19.8 22 19.1
Unemployed 4 4 12 10.4
Never employed 0 0 3 2.6
No response 1 1 1 0.9
Income
Less than $5,000 6 6 9 7.8
0.969
$5,000–$9,999 18 18 15 13
$10,000–19,999 16 16 19 16.5
$20,000–$39,999 14 14 15 13
$40,000-or More 9 9 11 9.6
Don’t know 20 20 26 22.6
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Table 2: Continued.
Variable
Telemed (N = 101) Control (N = 116) P-value1
n % n %
No response 17 17 20 17.4
Self-rate overall health at baseline
Excellent 2 2 2 1.7
0.085
Very good 3 3 16 13.9
Good 22 21.8 22 19.1
Fair 47 46.5 50 43.5
Poor 27 26.7 25 21.7
Who lives with patient
Spouse 23 22.8 26 22.6
0.905
Other relative 39 38.6 47 40.9
Friend 4 4 2 1.7
Other 1 1 1 0.9
No one 34 33.7 39 33.9
Avail. Of Primary Caregiver
No 6 5.9 8 7
0.096Yes 87 86.1 103 89.6
Don’t know 8 7.9 2 1.7
No response 0 0 2 1.7
# of overnight hosp. in past 12 months
Not at all 8 7.9 7 6.1
0.935One time 24 23.8 29 25.2
Two or three 36 35.6 39 33.9
More than three times 33 32.7 40 34.8
# of physician or clinic visits past 12 months
Not at all 2 2 4 3.5
0.331
once 3 3 0 0
2-3 times 8 7.8 9 7.8
4–6 times 31 30.7 30 26.1
more than 6 times 57 56.4 72 62.6
Severity of illness from home care OASIS
Asymptomatic, no treatment needed at this time 0 0 0 0
0.114
Symptoms well controlled with current therapy 0 0 2 1.8
Symptoms controlled with difficulty, affecting
daily functioning; patient needs ongoing monitoring
52 51.5 72 63.2
Symptoms poorly controlled; patient needs frequent
adjustment in treatment and dose monitoring
40 39.6 30 26.3
Symptoms poorly controlled; history of
re-hospitalizations
9 8.9 10 8.8
Variable N mean SD N mean SD P-value2
Age (yrs.) 101 71.3 10.2 116 73.5 9.6 0.092
CHF (months) 101 60.7 67.7 115 61.5 71.6 0.935
# Concomitant Medications 95 11.3 4.6 113 10.0 3.4 0.020
# Comorbid Conditions 101 6.8 4.0 116 6.0 4.0 0.145
Notes: 1Chi-square test 2T-Test, one patient in the control group had an incomplete baseline interview and medication counts were unobtainable for nine
patients enrolled from hospitals outside the health system.
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Table 3: Results from cox proportional hazards modeling of time to first all-cause readmission or death.
Variable Estimate SE HR 95% CI P
group TH −0.204 0.205 0.816 0.546 1.22 0.319
age −0.007 0.010 0.993 0.974 1.01 0.508
nmed 0.040 0.025 1.041 0.992 1.09 0.106
SE: Standard Error; HR: Hazard Ratio; TH: Telehealth.
Table 4: Number and percentage of readmissions by time period and group.
All-cause readmission
Group
0–30 days 31–60 days 61–120 days 121–180 days
n (%) n (%) n (%) n (%)
Control 22 (19%) 22 (19%) 27 (23%) 26 (22%)
Telehealth 16 (16%) 20 (20%) 20 (20%) 23 (23%)
Heart failure-related readmission
Group
0–30 days 31–60 days 61–120 days 121–180 days
n (%) n (%) n (%) n (%)
Control 10 (9%) 4 (3%) 13 (11%) 9 (8%)
Telehealth 8 (8%) 9 (9%) 9 (9%) 8 (8%)
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Figure 2: Kaplan-Meier survival curve of time to first all-cause
readmission or death for telehealth group versus control usual care
group (LR P-value = 0.585).
121–180 days there were no significant differences by group
after controlling for age and number of medications (P =
0.230, 95% CI 0.536 to 1.161) for all-cause and heart failure-
related readmissions (P = 0.977, 95% CI = 0.555–1.769)
(Table 5).
3.4. Number of All-Cause and Heart Failure-Related Hospital
Days. Mean number of hospital days for all-cause readmis-
sions occuring 0–30 days after index discharge was 1.41
± 4.05 for usual care and 0.91 ± 2.49 for telehomecare
patients (Table 6). Mean number of hospital days for heart
failure-related readmissions for same time period was 0.38 ±
1.38 for control versus 0.48 ± 1.75 for telehomecarepatients
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Figure 3: Kaplan-Meier survival curve of time to ED use for
telehealth group versus control usual care group (LR P-value =
0.699).
(Table 6). If readmitted, the hospital days between the tele-
homecare and usual care groups showed no significant dif-
ference for all-cause (P = 0.260, CI = 0.468–1.227) and heart
failure-related stays (P = 0.523, CI = .634–2.44) by six
months (Table 7).
3.5. Time to Emergency Department Use. In Figure 3 the
Kaplan-Meier Survival Curve and log rank test shows that
there is no significant difference in time to ED use between
intervention and control group (log-rank P = 0.699). A
Cox proportional hazards model was used to compare inter-
vention and control group for the time to first readmission
adjusting for age and number of medications and found no
significant difference, P = 0.231 (Table 8).
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Table 5: Results from GEE model for readmissions.
All cause Heart failure related
Exp (B) SE 95% CI P Exp (B) SE 95% CI P
Period 31–60 1.070 0.205 0.716 1.600 0.743 0.737 0.342 0.377 1.442 0.373
Period 61–120 0.686 0.189 0.474 0.993 0.046 0.605 0.302 0.335 1.093 0.096
Period 121–180 0.791 0.209 0.525 1.191 0.261 0.526 0.343 0.269 1.031 0.061
group TH 0.790 0.197 0.537 1.162 0.230 0.992 0.295 0.556 1.769 0.978
age 0.989 0.010 0.970 1.008 0.245 0.986 0.017 0.953 1.021 0.427
nmed 1.018 0.023 0.972 1.065 0.450 1.004 0.039 0.931 1.083 0.917
SE: Standard Error, TH: Telehealth Group; Baseline categories: 0–30 days for Period and Control for Group.
Table 6: Mean and SD of hospital days by time period and group.
All-cause readmission
Group
0–30 days 31–60 days 61–120 days 121–180 days
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Control 1.41 (4.05) 1.07 (3.07) 2.41 (7.72) 2.02 (5.22)
Telehealth 0.91 (2.49) 1.17 (3.21) 1.49 (4.53) 2.03 (5.28)
HF related-readmission
Group
0–30 days 31–60 days 61–120 days 121–180 days
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Control 0.38 (1.38) 0.11 (0.72) 0.88 (3.13) 0.32 (1.37)
Telehealth 0.48 (1.75) 0.41 (1.55) 0.68 (3.48) 0.49 (1.94)
Table 7: Results from GEE model for hospital days.
All-cause Heart failure-related
Exp (B) SE 95% CI P Exp (B) SE 95% CI P
Period 31–60 0.911 0.270 0.536 1.548 0.731 0.587 0.361 0.289 1.191 0.140
Period 61–120 0.831 0.254 0.505 1.366 0.464 0.837 0.381 0.396 1.768 0.641
Period 121–180 0.871 0.264 0.519 1.461 0.601 0.467 0.370 0.226 0.966 0.040
group TH 0.758 0.246 0.468 1.227 0.260 1.245 0.344 0.634 2.445 0.524
age 0.973 0.013 0.949 0.998 0.035 0.979 0.019 0.944 1.016 0.262
nmed 1.003 0.029 0.947 1.061 0.931 1.002 0.041 0.924 1.086 0.968
SE: Standard Error, TH: Telehealth Group; Baseline categories: 0–30 days for Period and Control for Group.
3.6. Emergency Department Use. By 30 days, 10% of control
group patients and 10% of telehomecare patients had at least
one ED visit (P = 0.939). By six months 30% (n = 35) versus
33% (n = 33) of control versus telehomecare patients used
the ED (P = 0.832) (Table 9). Overall, including 0–30 days,
31–60 days, 61–120 days, and 121–180 days there were no
significant differences by group for emergency department
visits after controlling for age and number of medications
(P = 0.940, 95% CI 0.580–1.657) (Table 10).
3.7. Access to Care. The mean number of in-person home
visits during the initial home care episode (including recerti-
fication) for telehomecare patients was 5.0 nursing visits (SD
1.8) and 4.2 (SD 1.1) for usual care patients, P = .013. Over
the entire six month study period, patients in the telehome-
care group received on average 11 home visits (SD 8.9) and
control group patients received on average 8 home visits (SD
4.6). This was significantly more in person contact for the
telehomecare patients than the usual care patients (P < .001).
Telehomecare patients were recertified for an additional
episode of home care significantly more often than control
group patients (24% compared to 9%, P = 0.003). The
length of the initial home care episode for telehomecare
patients was significantly longer at 54 days (SD 41) compared
to usual care patients at 35 days (SD 23), P < 0.001. On
average telehomecare patients who accepted the equipment
received three video visits and used the monitoring devices
81% of the available days (SD-24, range 6%–100%).
3.8. Patient Satisfaction. Patients in both groups were equally
satisfied that they received enough home visits (89% of usual
care group and 84% of telehomecare patients rated this item
agree or strongly agree). But when asked specifically if they
felt they were discharged too soon, 75% of usual care patients
said agree or strongly agree while only 25% of telehomecare
patients reported this (P = 0.03). In addition, 7% of usual
care patients were not satisfied that they knew how to contact
their nurse while no telehomecare patients reported this (P =
0.02).
4. Discussion
By 30 days, telehomecare patients were readmitted 3%
less often than usual care patients for all causes and 1%
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Table 8: Results from cox proportional hazards modeling of time to ED use.
Variable Estimate SE HR 95% CI P
group TH −0.248 0.208 0.78 0.519 1.171 0.231
age −0.008 0.01 0.992 0.973 1.012 0.448
nmed 0.029 0.025 1.029 1.029 0.98 0.245
SE: Standard Error; HR: Hazard Ratio; TH: Telehealth.
Table 9: Number and percent of ED visits by time period and group.
Group
0–30 days 31–60 days 61–120 days 121–180 days
n (%) n (%) n (%) n (%)
Control 12 (10%) 4 (3%) 14 (12%) 13 (1%)
Telehealth 10 (10%) 7 (7%) 14 (14%) 13 (13%)
Table 10: Results from GEE model for ED visits.
Parameter Exp (B) SE 95% CI P
Period 31–60 0.480 0.361 0.237 0.973 0.042
Period 61–120 0.660 0.253 0.402 1.083 0.100
Period 121–180 0.640 0.289 0.364 1.127 0.122
group TH 0.980 0.268 0.580 1.657 0.940
age 0.965 0.014 0.938 0.992 0.013
nmed 1.015 0.033 0.951 1.083 0.661
E: Standard Error, TH: Telehealth Group; Baseline categories: 0–30 days for Period and Control for Group.
less for heart failure-related cause. By 60 days the overall
difference in readmissions was 6% less for telehomecare
patients. Although not statistically significant, Lubell states
that decreasing readmissions by just 5% could save Medicare
five billion dollars annually [44].
Differences in success rates with telehomecare may be
due to patient and study site characteristics [16]. Two
recent systematic reviews report that telehealth monitoring
decreased the rate of heart failure readmissions by 21% [45],
or 27% to 46% [19]. These reviews included all adult patients
(18 and older) and either excluded home care patients [45] or
combined studies with homebound and ambulatory patients
[19]. Homebound status is a requirement for Medicare pay-
ment in the United States; so our study focused on older
adult, homebound home care recipients, with a majority of
African American race (65%), which may create a higher
risk cohort than other studies. Soran and colleagues [46, 47]
found no significant difference in readmission outcomes in a
similar female, nonwhite, and older cohort of 315 subjects.
A meta-analysis by Dellifraine and Dansky [20] reported
statistically lower effect sizes in studies with mostly women
d = 0.32 compared to d = 0.77 in studies with mostly men,
d = 0.41 with the elderly compared to d = 0.61 with all
adult subjects, and differences of d = 0.36 for mostly black
compared to d = 0.65 for mostly white subjects.
Soran and colleagues [47] suggest that differences in tele-
homecare study outcomes may arise from sites where heart
failure treatments are already optimized. The control group
30-day HF readmission rate in our study was only 9% while
the national 30-day HF readmission rate is nearly 24% [3].
Systematic reviews are showing decreases in HF readmission
rates of 21–46% with telehealth [2, 8, 19, 45]. The low rate
experienced at our study agency may have made it harder to
show a difference. Additionally, the study was powered at a
time when the readmission rate was 37%.
The success of telehomecare interventions also depends
on the context and skill with which they are applied. This
study suffered from several problems that most likely
impacted the ability to show a difference. The rate of patient
acceptance of the technology was less than optimal. Nearly
one-fourth of the sample refused to use or allow installation
of the telehomecare equipment once it arrived in the home.
Patients reported “feeling too sick to bother” with the
technology. Strategies may include having the physician
encourage the patient to do telemonitoring or involving
family members to assist. The study targeted Medicare
recipients making it an older sample, while findings indicated
that the younger patients were more accepting of telehealth.
Other studies experienced similar difficulties. Chaudhry et
al. [17] had 14% of patients that did not use the system at
all and Capomolla et al. [16] reported that 18% failed to use
their system. Providing equipment that is simple, easy to set-
up, and easy to use might help. Helping patients to see the
benefit for them may increase motivation. Offering telehealth
outside of the context of a study may also help as some
patients did not want to be bothered with the obligation of
follow-up interviews. Finally, buy-in from home care nurses
to support and encourage the use of technology is a key
facilitator. These issues decreased the size of the sample with
exposure to the intervention resulting in a lack of power
to show statistical significance. Other investigators have
experienced these same barriers and more [11, 48–50].
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Clinicians at the study site were not experienced with
using telehomecare, but Chaudhry et al. [17] found no
difference in outcomes in sites experienced with telehealth or
not. Perhaps more important is the ability to respond quickly
to changes in patient symptoms. Desai and Stevenson [51]
recommend using an independent mid-level professional
such as a nurse practitioner to provide timely treatment.
In our study, communication flowed from the telehomecare
nurse to the home care nurse, then to the primary physician
using the telephone, which may have resulted in less than
optimum responsiveness. Having a clinician who can provide
changes in the medical treatment directly is likely to improve
response time.
Several home care policies and procedures created bar-
riers to study goals. Decreasing in-person visits was difficult
because the agency nurses were evaluated based on produc-
tivity defined as the number of completed in-person visits
per day. To decrease visits would decrease their productivity
as measured. Buy-in must exist from the top and middle
managers, and within the nurses to ensure recognition for
the time and effort spent on telehealth activities. Nurses felt
pressured by middle managers to complete in-person visits to
maintain productivity standards leaving less time to devote
to telehealth activities. The agency did not recognize a video
visit as part of their productivity; so there was no incentive
for a nurse to eliminate an in-person visit. Further, if their
“productivity” fell, they would be given a new admission
therefore increasing the number of patients for whom
they were responsible without added compensation. Agency
management should recognize the workload contribution of
telehomecare nurses and count the effort afforded to install,
teach, monitor, and manage the clinical responses to the data.
However, at this point the reimbursement incentives within
homecare do not support this.
Despite the study goal, and continuous reminders to the
clinicians to be efficient and reduce the number of in-person
visits using the technology, telehomecare patients received
more in-person visits and were recertified for more home
care than usual care patients. In most cases, intervention
patients had more interaction with home health agency staff.
Not only did telehealth patients have a field nurse, but
also they had a telehealth nurse as well. Perhaps between
the two nurses one or the other influenced recertification.
Also, telehealth captures alterations in health status that
may have gone unnoticed in the control group leading
nurses to conclude that their patient was not stable enough
for discharge. It is also possible that the telehealth nurse
influenced the field nurse to recertify intervention patients as
patients who utilized the technology liked using it and may
have expressed this to the field or telehealth nurse, making
recertification more common among this group.
Most studies use telehealth technology in addition to
home visiting [12, 15, 20, 52–55]. To our knowledge, only
one published study [48] (since our study was designed)
attempted to decrease home care visits using telehomecare
and also was not successful. This nonrandomized study gave
telehealth to patients who would accept it compared to those
who refused. Only 3% used the system more often than
weekly. When analyzing 15 high users, they found that home
visits did decrease for 9 of the 15, but not for the majority of
the samples. One possible explanation for more visits is the
monitoring alerts clinicians to symptoms which may prompt
them to assess the patient in person. Further study is needed
to fully understand why telehomecare patients received more
visits and more recertification. Financial incentives to nurses
for using the technology more efficiently are also needed.
Telehomecare patients expressed more satisfaction with
home care than usual care patients in areas associated with
access to care. They felt better prepared for how to contact
their nurse and fewer expressed feeling discharged too soon.
Given the fact that telehomecare patients were kept in
home care longer, communicated both in-person and via
video, and received more visits may explain the finding. In
general telehealth studies report patient satisfaction with the
technology [27, 56].
4.1. Limitations. This study was conducted in one home care
agency in Southeastern Pennsylvania. The agency had no
experience with telehomecare and therefore had to create
new workflow procedures and generate enthusiasm for the
new clinical program. Patients were limited to those 55 and
older with a heart failure hospitalization within two weeks
of enrollment and cognitively intact. Twenty-four percent
of telehomecare group patients refused to use the equip-
ment. The study sample was largely older, African-American
females.
5. Future Research
Further research is needed to determine the ideal pop-
ulation for telehomecare effectiveness. Workflow must be
carefully designed to support fidelity to the intervention
and motivation of patients and nurses to use the equipment
as prescribed. Protocols that support treatment parameters
for rapid response need developed and tested. Financial
incentives to use the technology efficiently are sorely needed.
In addition, little is known about the ideal duration of
monitoring or combination of case management, telephone
use, and remote monitoring.
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